Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

All content curated by

Mark Hallett MD

Argye Hillis MD, MA

Avindra Nath MD

See All Experts

Published in Neurology and

Journal Scan / Research · May 14, 2023

Nabiximols Oromucosal Spray in Patients With MS-Related Bladder Dysfunction

Multiple Sclerosis and Related Disorders

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Ahmed Obeidat MD, PhD

Multiple Sclerosis and Related Disorders

Nabiximols oromucosal spray in patients with multiple sclerosis-related bladder dysfunction: A prospective study

Mult Scler Relat Disord 2023 Apr 09;74(xx)104711, V Torri Clerici, L Brambilla, PL Politi, F Viggiani, S Mercurio, S Tonietti, M Ronzoni, SG Crisafulli, C Antozzi, I Tramacere, C Redemagni, P Confalonieri

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Multiple Sclerosis

Nabiximols Oromucosal Spray in Patients With MS-Related Bladder Dysfunction

Additional Info

Nabiximols oromucosal spray in patients with multiple sclerosis-related bladder dysfunction: A prospective study

Further Reading

Relevance of Genetic Testing in the Gene-Targeted Trial Era

Adjunctive Cenobamate Therapy in People With Focal-Onset Seizures

Safety and Efficacy of Staged Bilateral Focused Ultrasound Thalamotomy in Patients With Essential Tremor

Use of the Combination of Spirometry, Arterial Blood Gas Analysis, and Overnight Oximetry to Predict Outcomes in Patients With Motor Neuron Disease: The Milan–Torin Respiratory Score

Risk of Major Bleeding, Stroke/Systemic Embolism, and Death Associated With Different Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease

The Recombinant Shingles Vaccine Is Associated With a Lower Risk of Dementia

Association Between Alcohol Consumption and Disability Accumulation in Patients With MS

Endovascular Therapy vs Best Medical Management for Acute Ischaemic Stroke Due to Distal Medium Middle Cerebral Artery Occlusion

Use of Serum Biomarkers at Disease Onset for Personalized Therapy in Patients With MS

Re-PROGRAM: A Brief Intervention Program for Patients With Functional Seizures in an Outpatient Hospital Setting

FDA Approves Voranigo for Grade 2 Astrocytoma or Oligodendroglioma

Recently Updated